US FTC files complaint against Impax, Endo over agreement regarding painkiller
MLex Summary: The US Federal Trade Commission filed a complaint accusing Endo Pharmaceuticals, Impax Laboratories and Impax’s owner, Amneal Pharmaceuticals, of illegally conspiring to limit competition in the market for oxymorphone...To view the full article, register now.
Already a subscriber? Click here to view full article